Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Defining breast cancer quality care around the globe

Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC

Highlights from APCCC 2026

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma

Education and training in breast cancer care

QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials

The Vanessa Moss Prize: celebrating research into cancer health disparities

Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

Improving cancer care by partnering not-for-profits based in the UK and Ireland with colleagues in LMICs